Retinal implants have gained increasing interest since it was demonstrated in acute trials that completely blind subjects do have light perception upon electrical stimulation of the inner surface ...

Pioneered by Italian ophthalmologist Benedetto Strampelli in the early 1960s, tooth-in-eye surgery is intended to minimize ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

Vivani was created in 2022 when subdermal drug implant company Nano Precision Medical merged with implantable visual ...

Inside the human eye, the retina is made up of several types of cells, including the light-sensing photoreceptors that initiate the cascade of events that lead to vision.

Vivani Medical, Inc. (NASDAQ:VANI) said it intends to spin off Cortigent, Inc., a division that develops brain implant ...

The implant was also shown to be safe and well ... director of research at Retinal Consultants of Texas and an investigator in the Encelto clinical trials, said in Neurotech’s approval announcement.

Phase 3 trials demonstrated ENCELTO significantly slowed macular photoreceptor loss in MacTel patients over 24 months.

New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients ...

we examined the surgical outcomes of patients with glaucoma requiring a scleral buckle for retinal detachment repair who underwent concomitant scleral buckle and Baerveldt glaucoma implant (BGI ...

The US Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular ...

Warnings and Precautions: The SUSVIMO implant and the procedures associated ... macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME ...